Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer.
Swiecicki PL, Yilmaz E, Rosenberg AJ, Fujisawa T, Bruce JY, Meng C, Wozniak M, Zhao Y, Mihm M, Kaplan J, Gorla S, Geiger JL.
Swiecicki PL, et al. Among authors: zhao y.
J Clin Oncol. 2024 Oct 31:JCO2400646. doi: 10.1200/JCO.24.00646. Online ahead of print.
J Clin Oncol. 2024.
PMID: 39481054